Abera Bioscience AB (NGM:ABERA)
9.30
-0.64 (-6.44%)
At close: Jul 3, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 190.64 million as of July 2, 2026. Its market cap has increased by 70.10% in one year.
Market Cap
190.64M
Enterprise Value
164.60M
Revenue
11.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.30
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 190.64M, an increase of 64.93%. That is a compound annual growth rate of 9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 190.64M | 51.98% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nodebis Applications AB | 230.54M |
| Xer Tech Holding AB | 209.76M |
| Eurobattery Minerals AB | 205.01M |
| Invoicery Group AB | 201.87M |
| Link Prop Investment AB | 199.92M |
| Fable Media Group AB | 198.39M |
| Triona AB | 198.38M |
| Spotlight Group AB | 190.86M |